Genetics of Congenital Heart Disease
Recruiting now
Conditions studied: Congenital Heart Disease
In brief
Congenital heart disease (CHD) is the most common type of birth defect but the cause for the majority of cardiac birth defects remains unknown. Numerous epidemiologic studies have demonstrated evidence that genetic factors likely play a contributory, if not causative, role in CHD. While numerous genes have been identified by us and other investigators using traditional genetic approaches, these genes account for a minority of the non-syndromic CHDs. Therefore, we are now utilizing whole genome sequencing (WGS), with the addition of more traditional genetic techniques such as chromosomal microarray or traditional linkage analysis, to identify genetic causes of familial and isolated CHD. With WGS we are able to sequence all of the genetic material of an individual and apply different data analysis techniques based on whether we are analyzing a multiplex family or a cohort of trios (mother, father and child with CHD) with a specific isolated CHD. Therefore, WGS is a robust method for identification of novel genetic causes of CHD which will have important diagnostic and therapeutic consequences for these children.
Key facts
- Study ID
- NCT01192048
- Run by
- Nationwide Children's Hospital
- People needed
- 5000
- Starts
- 2009-12-01
- Expected to finish
- 2030-12-01
- Last updated by the study team
- 2026-04-07
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Subjects must have a diagnosis of Congenital Heart Disease or be related to individuals with Congenital Heart Disease.
You may not qualify if…
- Healthy individuals unrelated to those with Congenital Heart Disease
Where it is running
- Nationwide Children's Hospital — Columbus, Ohio, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.